Stay updated on Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The history shows a new revision entry, Revision: v3.6.3, added to replace the previous Revision: v3.6.2.
    Difference
    0.1%
    Check dated 2026-07-04T13:36:27.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The history page shows a new Revision: v3.6.2 label replacing the prior v3.6.0, signaling a minor software update to the record history interface.
    Difference
    0.1%
    Check dated 2026-06-27T06:50:26.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The history now shows 'No longer looking for participants' and adds Revision: v3.6.0, while removing Revision: v3.5.5. This reflects a recruitment status update and an updated version in the study record.
    Difference
    0.3%
    Check dated 2026-06-13T01:16:45.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The revision label on the history page advanced from v3.5.4 to v3.5.5, indicating a minor update to the page's revision metadata.
    Difference
    0.1%
    Check dated 2026-06-05T22:17:25.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    A new revision entry (v3.5.4) was added to the study record history, representing an updated submission to the record. The previous revision (v3.5.3) was removed from the visible history.
    Difference
    0.1%
    Check dated 2026-05-15T06:14:53.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The page’s UI/version label was updated from “Revision: v3.5.2” to “Revision: v3.5.3.” This reflects a change in the site’s revision/version rather than a modification to the underlying clinical trial record.
    Difference
    0.1%
    Check dated 2026-04-24T05:51:20.000Z thumbnail image

Stay in the know with updates to Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial page.